SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318154-22-000021
Filing Date
2022-04-28
Accepted
2022-04-27 20:00:34
Documents
79
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amgn-20220331.htm   iXBRL 10-Q 2091399
2 AMGEN INC. EXECUTIVE INCENTIVE PLAN amgn-ex1017_2022331xq1.htm EX-10.17 28055
3 RULE 13A-14(A) CERTIFICATIONS amgn-ex31_20221231xq1.htm EX-31 19968
4 SECTION 1350 CERTIFICATIONS amgn-ex32_2022331xq1.htm EX-32 9622
  Complete submission text file 0000318154-22-000021.txt   9390531

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amgn-20220331.xsd EX-101.SCH 63864
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amgn-20220331_cal.xml EX-101.CAL 71116
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amgn-20220331_def.xml EX-101.DEF 369177
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amgn-20220331_lab.xml EX-101.LAB 729605
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amgn-20220331_pre.xml EX-101.PRE 505270
73 EXTRACTED XBRL INSTANCE DOCUMENT amgn-20220331_htm.xml XML 1765388
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37702 | Film No.: 22861648
SIC: 2836 Biological Products, (No Diagnostic Substances)